India's first wave of healthtech was built for cities: app-based doctor consultations, online pharmacies and diagnostics aimed at urban consumers who already had smartphones and disposable income. The harder and arguably more important frontier lies beyond the metros — in the tier-2 and tier-3 towns and rural districts where doctors are scarce, specialists scarcer, and quality diagnostics often hours away.
The gap
Healthcare access in India is highly uneven. A large share of specialists cluster in big cities, leaving smaller towns dependent on overstretched clinics. Telemedicine promised to close that distance, and the pandemic accelerated its acceptance; the government's own eSanjeevani telemedicine service handled a very large volume of remote consultations, demonstrating latent demand for care delivered over a phone.
What expansion looks like
Companies such as Practo, Tata 1mg and others have worked to extend consultations, medicine delivery and lab tests beyond metros, often by combining a digital front end with local physical touchpoints — sample-collection agents, partner pharmacies and diagnostic labs. The model has to adapt: lower price points, vernacular interfaces, support for users less comfortable with apps, and logistics that reach places large-format retail never did.
The obstacles are structural — thin margins, fragmented supply, regulatory complexity in pharmacy and diagnostics, and the simple difficulty of building trust for medical services delivered remotely. But the size of the underserved population makes the effort worthwhile. If healthtech's first act was convenience for the connected, its second is access for the many, and that story is being written in India's smaller towns.
